News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

Looking for an easier way to sort and quantify key cellular information from immunofluorescent images? NCI-funded researchers have a new semi-automated tool, called “GammaGateR,” that may help.

Are you a tool developer who wants to apply your skills to support cancer research? Consider registering for this challenge where you’ll develop an analysis tool to integrate with NCI’s Genomic Data Commons.

If you’re working with NIH genomic data, you’ll need to be aware of some new security requirements for data management and access that take effect on January 25, 2025. Learn more about how this could impact your work.

With the help of machine learning, NCI-funded researchers were able to boost the prognostic power of a common blood test for liver cancer.

NCI staff contributed to an October 2023 publication that highlights how the Global Alliance for Genomics and Health (GA4GH) coalition is creating a more equitable, diverse, and inclusive environment within its standards and members. This is to prevent continuing biases in genomics data collection methods and the genomics workforce. By taking actions to address such changes, the GA4GH coalition hopes to inspire others to do the same and make genomic data more representative of the global community.

Want to identify existing gene mutations more accurately and discover new signatures more efficiently? There’s a new NCI-funded tool, the Mutational Signature Calculator, that can help improve your standard workflow.

Are you having trouble prioritizing which genetic variants to study in your cancer research? There’s a new platform, called FORGEdb, that can help you pinpoint promising variants and target genes.

Interested in blending clinical and genetic data? Upgrades in cBioPortal can help you work with these very different data types to better understand cancer and how it progresses over time.

Do you conduct research on statistical and analytical methods, cancer survivorship, digital health, and/or data science tools and methods? Apply for an R01 grant from NCI’s Division of Cancer Control and Population Sciences by June 5 or October 5, 2024.

What if you could predict how a chemotherapy drug would work—in terms of sensitivity and side-effects—before you ever use it? NCI-funded researchers are using machine learning models to better understand a key mechanism underlying cancer, giving us new ways to predict responses to common chemotherapy drugs.